Motilal Oswal Maintains Buy Rating on Niva Bupa with ₹100 Target

Motilal Oswal retained its bullish stance on Niva Bupa Health Insurance with a target price of ₹100, projecting a potential 31% upside.

The insurance company's shares recovered 1.63% on Friday to close at ₹77.38 following a previous dip triggered by IRDAI's proposed draft industry reforms.

While management noted that distribution changes and lower commissions under the draft norms may impact near-term volume growth, they view them as a medium-term positive.